Top Markets
Coin of the day
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.

Samsung Biologics Co.,Ltd.

207940
株式のランク #513
Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon,... Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
株価
$1,073.54
時価総額
$49.70B
変化(1日)
0.23%
変化(1年)
-7.37%
KR
取引 Samsung Biologics Co.,Ltd. (207940)

カテゴリー

Samsung Biologics Co.,Ltd.(207940)の配当利回りの履歴
Samsung Biologics Co.,Ltd.(銘柄コード: 207940)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Samsung Biologics Co.,Ltd.(207940)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)
企業 配当利回り
0.00%
US
0.00%
NL
0.00%
CH
0.65%
BE
3.46%
AU